Sign Up to like & get
recommendations!
0
Published in 2021 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2021.1970744
Abstract: ABSTRACT Introduction A number of anti-diabetic treatments have been favored during the continuing spread of the current SARS-CoV-2 pandemic. Glucagon like peptide-1 receptor agonists (GLP1-RAs) are a group of antidiabetic drugs, the glucose reducing effect…
read more here.
Keywords:
hypothetical molecular;
glp1 ras;
receptor agonists;
molecular mechanism ... See more keywords